154 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
7 May 24
Cogent Biosciences Reports First Quarter 2024 Financial Results
8:19am
as other mutations in KIT
exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation
8-K
EX-10.1
piawdfetvcaajwv
22 Mar 24
Unregistered Sales of Equity Securities
8:33am
8-K
EX-99.1
rtyr5duy9ld
26 Feb 24
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
8:30am
8-K
EX-10.2
mn57657dx fi1iya
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-10.1
qmrm7nl1eusp633
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-99.1
0ixjtk4jh0dq3nlv
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-99.1
vv6hekp3ik ov0um8i12
2 Nov 23
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results
9:18am